{"AllianceGenome": "986", "HGNC": "986", "MIM": "608348", "_id": "593", "_version": 1, "accession": {"genomic": ["AC011462.4", "AH003707.2", "AH003771.2", "CH471126.1", "CP068259.2", "KT223000.1", "KT223001.1", "KT223002.1", "NC_000019.10", "NC_060943.1", "NG_013004.1", "S38309.1"], "protein": ["AAA35590.1", "AAB19267.1", "AAB19268.2", "AAB20222.2", "AAB59549.1", "AAH07878.1", "AAH08933.1", "AAH23983.1", "ALB78331.1", "ALB78332.1", "BAD93065.1", "BAG36106.1", "BAG60459.1", "CAA78475.1", "CAH56215.1", "EAW57039.1", "EAW57040.1", "NP_000700.1", "NP_001158255.1", "P12694.2", "QVG60136.1", "QVG60137.1", "QVG60138.1", "QVG60139.1"], "rna": ["AB209828.1", "AK298188.1", "AK313300.1", "AL833143.1", "BC007878.2", "BC008933.2", "BC023983.1", "BE223026.1", "BG742673.1", "BI910860.1", "BM702667.1", "BQ018849.1", "J04474.1", "M22221.1", "MT021997.1", "MT021998.1", "MT021999.1", "MT022000.1", "MT022001.1", "MT022002.1", "MT022003.1", "MT022004.1", "NM_000709.4", "NM_001164783.2", "Z14093.1"], "translation": [{"protein": "NP_000700.1", "rna": "NM_000709.4"}, {"protein": "CAH56215.1", "rna": "AL833143.1"}, {"protein": "CAA78475.1", "rna": "Z14093.1"}, {"protein": "QVG60137.1", "rna": "MT022001.1"}, {"protein": "AAH07878.1", "rna": "BC007878.2"}, {"protein": "QVG60136.1", "rna": "MT022000.1"}, {"protein": "AAB59549.1", "rna": "J04474.1"}, {"protein": "BAG36106.1", "rna": "AK313300.1"}, {"protein": "QVG60139.1", "rna": "MT022003.1"}, {"protein": "AAA35590.1", "rna": "M22221.1"}, {"protein": "NP_001158255.1", "rna": "NM_001164783.2"}, {"protein": "BAG60459.1", "rna": "AK298188.1"}, {"protein": "AAH08933.1", "rna": "BC008933.2"}, {"protein": "QVG60138.1", "rna": "MT022002.1"}, {"protein": "AAH23983.1", "rna": "BC023983.1"}, {"protein": "BAD93065.1", "rna": "AB209828.1"}]}, "alias": ["BCKDE1A", "MSU", "MSUD1", "MSUD1A", "OVD1A"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2018-09-14T16:00:00.000Z", "disease_label": "maple syrup urine disease type 1A", "gcep": "Aminoacidopathy Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0023691", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5c89a6c7-751a-4a99-8a32-97cc33c5df7c-2018-09-14T160000.000Z", "sop": "SOP6"}}, "ec": "1.2.4.4", "ensembl": {"gene": "ENSG00000248098", "protein": ["ENSP00000269980", "ENSP00000416000", "ENSP00000440345", "ENSP00000445727", "ENSP00000445809"], "transcript": ["ENST00000269980", "ENST00000457836", "ENST00000535632", "ENST00000538423", "ENST00000541315", "ENST00000542943", "ENST00000544905", "ENST00000545787"], "translation": [{"protein": "ENSP00000269980", "rna": "ENST00000269980"}, {"protein": "ENSP00000440345", "rna": "ENST00000542943"}, {"protein": "ENSP00000416000", "rna": "ENST00000457836"}, {"protein": "ENSP00000445809", "rna": "ENST00000541315"}, {"protein": "ENSP00000445727", "rna": "ENST00000544905"}], "type_of_gene": "protein_coding"}, "entrezgene": "593", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 16.8125847916, "exp_mis": 207.776073467, "exp_syn": 97.1234555015, "lof_z": 0.921068561295625, "mis_z": 1.75690389955812, "mu_lof": 1.239101841e-06, "mu_mis": 1.90369703971e-05, "mu_syn": 8.67735610456e-06, "n_lof": 13.0, "n_mis": 156.0, "n_syn": 89.0, "p_li": 7.66463791783609e-08, "p_null": 0.531385802593717, "p_rec": 0.468614120759903, "syn_z": 0.511008867614335}, "bp": 1338, "cds_end": 41930513, "cds_start": 41903732, "n_exons": 9, "nonpsych": {"exp_lof": 15.0409016502, "exp_mis": 187.881292035, "exp_syn": 87.7299875127, "lof_z": 1.27650708415025, "mis_z": 1.72512084950177, "mu_lof": 1.239101841e-06, "mu_mis": 1.90369703971e-05, "mu_syn": 8.67735610456e-06, "n_lof": 10.0, "n_mis": 141.0, "n_syn": 80.0, "p_li": 1.05192622758668e-05, "p_null": 0.226286642103799, "p_rec": 0.773702838633925, "syn_z": 0.519599105965464}, "nontcga": {"exp_lof": 15.4504125117, "exp_mis": 191.136835286, "exp_syn": 89.3364147988, "lof_z": 0.86592888232319, "mis_z": 1.77069942138828, "mu_lof": 1.239101841e-06, "mu_mis": 1.90369703971e-05, "mu_syn": 8.67735610456e-06, "n_lof": 12.0, "n_mis": 142.0, "n_syn": 85.0, "p_li": 2.62701172743376e-07, "p_null": 0.506659347837326, "p_rec": 0.493340389461501, "syn_z": 0.290494786183924}, "transcript": "ENST00000269980.2"}, "exons": [{"cdsend": 41424608, "cdsstart": 41397827, "chr": "19", "position": [[41397817, 41397935], [41410636, 41410816], [41410922, 41411009], [41414048, 41414157], [41419134, 41419296], [41422163, 41422370], [41422628, 41422770], [41422997, 41423169], [41424437, 41425002]], "strand": 1, "transcript": "NM_000709", "txend": 41425002, "txstart": 41397817}, {"cdsend": 41424608, "cdsstart": 41397827, "chr": "19", "position": [[41397817, 41397935], [41410636, 41410816], [41410922, 41411009], [41414048, 41414157], [41419134, 41419296], [41422163, 41422370], [41422631, 41422770], [41422997, 41423169], [41424437, 41425002]], "strand": 1, "transcript": "NM_001164783", "txend": 41425002, "txstart": 41397817}], "exons_hg19": [{"cdsend": 41930513, "cdsstart": 41903732, "chr": "19", "position": [[41903722, 41903840], [41916541, 41916721], [41916827, 41916914], [41919953, 41920062], [41925039, 41925201], [41928068, 41928275], [41928533, 41928675], [41928902, 41929074], [41930342, 41930907]], "strand": 1, "transcript": "NM_000709", "txend": 41930907, "txstart": 41903722}, {"cdsend": 41930513, "cdsstart": 41903732, "chr": "19", "position": [[41903722, 41903840], [41916541, 41916721], [41916827, 41916914], [41919953, 41920062], [41925039, 41925201], [41928068, 41928275], [41928536, 41928675], [41928902, 41929074], [41930342, 41930907]], "strand": 1, "transcript": "NM_001164783", "txend": 41930907, "txstart": 41903722}], "generif": [{"pubmed": 15322287, "text": "the conformational stability underlying the folding of this lipoic acid bearing domain of human mitochondrial branched chain alpha-ketoacid dehydrogenase"}, {"pubmed": 16757574, "text": "A list of nine primary candidate genes for T2D and five for obesity were identified in this paper. Two genes, LPL and BCKDHA, were common to these two sets."}, {"pubmed": 17922217, "text": "in our cohort more severe enzyme & clinical phenotypes of variant maple syrup urine disease were mainly associated with specific genotypes in BCKDHA gene; milder enzyme & clinical phenotypes were associated with specific genotypes in BCKDHB & DBT genes"}, {"pubmed": 18378174, "text": "30 Maple syrup urine disease Portuguese patients studied; 17 putative mutations have been identified (6 in BCKDHA, 5 in BCKDHB and 6 in DBT); 7 of are described for the first time."}, {"pubmed": 19085071, "text": "Case Report: Maple syrup urine disease due to a new large deletion at BCKDHA caused by non-homologous recombination."}, {"pubmed": 19456321, "text": "A founder mutation in the BCKDHA is responsible for the high incidence of the maple syrup urine disease among Portuguese Gypsies."}, {"pubmed": 19480318, "text": "In 37% (12 patients) of a total of 64 alleles, the supposed maple syrup urine disease-causing mutations in Turkish patients were located in the BCKDHA gene, in 44% (14 patients) in the BCKDHB gene and in 19% (6 patients) in the DBT gene."}, {"pubmed": 19715473, "text": "five mutations, three of them novel, responsible for maple syrup urine disease"}, {"pubmed": 20136525, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 20431954, "text": "Case Report: functional characterization of the novel intronic nucleotide change c.288+9C>T within the BCKDHA gene in maple syrup urine disease."}, {"pubmed": 20877624, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21844576, "text": "identified 4 novel mutations of the BCKDHA gene in 3 Korean newborns; to the best of knowledge, this is the first report of maple syrup urine disease confirmed by genetic analysis in Korea"}, {"pubmed": 22593002, "text": "BCKDHA and BCKDHB mutations might be primarily responsible for maple syrup urine disease in the Indian population."}, {"pubmed": 22956686, "text": "autism presenting with intellectual disability and epilepsy caused by BCKDK mutations represents a potentially treatable syndrome."}, {"pubmed": 23729548, "text": "Data from infant/her heterozygous parents (first cousins) suggest homozygous mutation (S144I) in BCKDHA can result in maple syrup urine disease (IA); molecular modeling suggests this missense mutation in exon 4 affects protein stability. [CASE STUDY]"}, {"pubmed": 24268812, "text": "The novel DBT mutation c.650-651insT was more prevalent than the deleted 4.7-kb heterozygote in the Amis population. The reported 4.7-kb deletion indicating a possible founder mutation may be preserved."}, {"pubmed": 24603436, "text": "Targeted parallel sequencing revealed novel mutations in the gene BCKDHA for prenatal testing of maple syrup urine disease."}, {"pubmed": 26453840, "text": "Five novel mutations in BCKDHA were identified in MSUD patients."}, {"pubmed": 26830710, "text": "we identified seven novel genetic variants: p.Leu549Pro, p.Glu564*, p.Leu641Pro in MUT, p.Tyr206Cys in PCCB, p.His194Arg, p.Val298Met in BCKDHA and p.Glu286_Met290del in BCKDHB gene. In silico and/or eukaryotic expression studies confirmed pathogenic effect of all novel genetic variants"}, {"pubmed": 29306928, "text": "Data suggest that the following genetic modifications are involved in patients with maple syrup urine disease in Iran: (1) mutation in BCKDHA (branched chain keto acid dehydrogenase E1 alpha); (2) mutation in BCKDHB (branched chain keto acid dehydrogenase E1 subunit beta); (3) mutation in DBT (dihydrolipoamide branched chain transacylase E2; one patient)."}, {"pubmed": 29307017, "text": "Six different novel genetic variants were validated in BCKDHB gene and BCKDHA gene, including c.523 T > C, c.659delA, c.550delT, c.863G > A and two gross deletions"}, {"pubmed": 29673582, "text": "pathogenic effect of a novel variant of BCKDHA leading to classical maple syrup urine disease"}, {"pubmed": 34511290, "text": "Association of BCAT2 and BCKDH polymorphisms with clinical, anthropometric and biochemical parameters in young adults."}, {"pubmed": 34883003, "text": "Three novel mutations of the BCKDHA, BCKDHB and DBT genes in Chinese children with maple syrup urine disease."}], "genomic_pos": {"chr": "19", "end": 41425002, "ensemblgene": "ENSG00000248098", "start": 41397808, "strand": 1}, "genomic_pos_hg19": {"chr": "19", "end": 41930910, "start": 41884215, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0009083", "qualifier": "involved_in", "term": "branched-chain amino acid catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0009083", "pubmed": [3593587, 7883996], "qualifier": "involved_in", "term": "branched-chain amino acid catabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0009083", "pubmed": [9582350, 10745006], "qualifier": "involved_in", "term": "branched-chain amino acid catabolic process"}], "CC": [{"evidence": "HDA", "gocategory": "CC", "id": "GO:0005739", "pubmed": 20833797, "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005739", "pubmed": 11839747, "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005759", "pubmed": 3593587, "qualifier": "located_in", "term": "mitochondrial matrix"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005759", "qualifier": "located_in", "term": "mitochondrial matrix"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0045252", "qualifier": "part_of", "term": "oxoglutarate dehydrogenase complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0045252", "pubmed": [7883996, 9582350], "qualifier": "part_of", "term": "oxoglutarate dehydrogenase complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0160157", "pubmed": 10745006, "qualifier": "part_of", "term": "branched-chain alpha-ketoacid dehydrogenase complex"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0003863", "pubmed": [9582350, 10745006], "qualifier": "contributes_to", "term": "3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003863", "pubmed": 7883996, "qualifier": "enables", "term": "3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [12902323, 15166214, 15576032, 28514442], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0016831", "pubmed": 11839747, "qualifier": "enables", "term": "carboxy-lyase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0047101", "pubmed": 3593587, "qualifier": "contributes_to", "term": "branched-chain alpha-keto acid dehydrogenase activity"}]}, "homologene": {"genes": [[3702, 830789], [4530, 4351684], [5141, 3876328], [6239, 176716], [7165, 1273808], [7227, 41149], [7955, 554124], [9544, 704978], [9598, 468889], [9606, 593], [9615, 484488], [9913, 282149], [10090, 12039], [10116, 25244], [318829, 2677190]], "id": 569}, "interpro": [{"desc": "Dehydrogenase, E1 component", "id": "IPR001017", "short_desc": "DH_E1"}, {"desc": "Thiamin diphosphate-binding fold", "id": "IPR029061", "short_desc": "THDP-binding"}], "ipi": ["IPI00025100", "IPI00910865", "IPI00944561", "IPI00974102", "IPI01010871"], "map_location": "19q13.2", "name": "branched chain keto acid dehydrogenase E1 subunit alpha", "other_names": ["2-oxoisovalerate dehydrogenase (lipoamide)", "2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial", "BCKDH E1-alpha", "branched chain keto acid dehydrogenase E1 alpha protein", "branched chain keto acid dehydrogenase E1, alpha polypeptide", "branched-chain alpha-keto acid dehydrogenase E1 component alpha chain"], "pantherdb": {"HGNC": "986", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "107701", "ortholog_type": "LDO", "panther_family": "PTHR43380", "taxid": 10090, "uniprot_kb": "P50136"}, {"RGD": "2196", "ortholog_type": "LDO", "panther_family": "PTHR43380", "taxid": 10116, "uniprot_kb": "P11960"}, {"Ensembl": "ENSGALG00000042246", "ortholog_type": "LDO", "panther_family": "PTHR43380", "taxid": 9031, "uniprot_kb": "A0A1D5NUJ3"}, {"ZFIN": "ZDB-GENE-050522-376", "ortholog_type": "LDO", "panther_family": "PTHR43380", "taxid": 7955, "uniprot_kb": "Q4VBU0"}, {"WormBase": "WBGene00012713", "ortholog_type": "LDO", "panther_family": "PTHR43380", "taxid": 6239, "uniprot_kb": "O45924"}, {"FlyBase": "FBgn0037709", "ortholog_type": "LDO", "panther_family": "PTHR43380", "taxid": 7227, "uniprot_kb": "Q9VHB8"}, {"dictyBase": "DDB_G0286335", "ortholog_type": "LDO", "panther_family": "PTHR43380", "taxid": 352472, "uniprot_kb": "Q54M22"}, {"TAIR": "2027072", "ortholog_type": "LDO", "panther_family": "PTHR43380", "taxid": 3702, "uniprot_kb": "Q9LPL5"}, {"TAIR": "2184702", "ortholog_type": "O", "panther_family": "PTHR43380", "taxid": 3702, "uniprot_kb": "Q84JL2"}], "uniprot_kb": "P12694"}, "pathway": {"humancyc": [{"id": "ILEUDEG-PWY", "name": "isoleucine degradation"}, {"id": "LEU-DEG2-PWY", "name": "leucine degradation"}, {"id": "PWY-5046", "name": "2-oxoisovalerate decarboxylation to isobutanoyl-CoA"}, {"id": "PWY-5130", "name": "2-oxobutanoate degradation"}, {"id": "PWY-5328", "name": "superpathway of methionine degradation"}, {"id": "PWY66-428", "name": "threonine degradation"}, {"id": "VALDEG-PWY", "name": "valine degradation"}], "kegg": [{"id": "hsa00280", "name": "Valine, leucine and isoleucine degradation - Homo sapiens (human)"}, {"id": "hsa00640", "name": "Propanoate metabolism - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-70895", "name": "Branched-chain amino acid catabolism"}, {"id": "R-HSA-71291", "name": "Metabolism of amino acids and derivatives"}, {"id": "R-HSA-9859138", "name": "BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV"}], "smpdb": [{"id": "SMP00032", "name": "Valine, Leucine and Isoleucine Degradation"}, {"id": "SMP00137", "name": "2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency"}, {"id": "SMP00138", "name": "3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency"}, {"id": "SMP00139", "name": "3-Methylglutaconic Aciduria Type I"}, {"id": "SMP00140", "name": "3-Methylglutaconic Aciduria Type III"}, {"id": "SMP00141", "name": "3-Methylglutaconic Aciduria Type IV"}, {"id": "SMP00173", "name": "Beta-Ketothiolase Deficiency"}, {"id": "SMP00199", "name": "Maple Syrup Urine Disease"}, {"id": "SMP00200", "name": "Methylmalonic Aciduria"}, {"id": "SMP00236", "name": "Propionic Acidemia"}, {"id": "SMP00237", "name": "3-Methylcrotonyl Coa Carboxylase Deficiency Type I"}, {"id": "SMP00238", "name": "Isovaleric Aciduria"}, {"id": "SMP00384", "name": "Methylmalonate Semialdehyde Dehydrogenase Deficiency"}, {"id": "SMP00452", "name": "Threonine and 2-Oxobutanoate Degradation"}, {"id": "SMP00521", "name": "3-hydroxyisobutyric acid dehydrogenase deficiency"}, {"id": "SMP00522", "name": "3-hydroxyisobutyric aciduria"}, {"id": "SMP00523", "name": "Isobutyryl-coa dehydrogenase deficiency"}, {"id": "SMP00524", "name": "Isovaleric acidemia"}], "wikipathways": {"id": "WP3965", "name": "Lipid Metabolism Pathway"}}, "pdb": ["1DTW", "1OLS", "1OLU", "1OLX", "1U5B", "1V11", "1V16", "1V1M", "1V1R", "1WCI", "1X7W", "1X7X", "1X7Y", "1X7Z", "1X80", "2BEU", "2BEV", "2BEW", "2BFB", "2BFC", "2BFD", "2BFE", "2BFF", "2J9F"], "pfam": "PF00676", "pharmgkb": "PA25297", "pharos": {"target_id": 8860, "tdl": "Tbio"}, "pir": "S27156", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF246271", "relationship": "is"}, {"id": "GNF246272", "relationship": "is"}, {"id": "GNF246273", "relationship": "is"}, {"id": "GNF246274", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF080147", "relationship": "is"}, {"id": "GNF080148", "relationship": "is"}, {"id": "GNF080149", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053558", "relationship": "is"}, {"id": "GNF058329", "relationship": "is"}, {"id": "GNF073537", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF071309", "relationship": "is"}, {"id": "GNF071310", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF001050", "relationship": "is"}, {"id": "GNF001051", "relationship": "is"}, {"id": "GNF001052", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF338447", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF099511", "relationship": "is"}, {"id": "GNF139166", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1", "NG_013004.1"], "protein": ["NP_000700.1", "NP_001158255.1"], "rna": ["NM_000709.4", "NM_001164783.2"], "translation": [{"protein": "NP_001158255.1", "rna": "NM_001164783.2"}, {"protein": "NP_000700.1", "rna": "NM_000709.4"}]}, "reporter": {"HG-U133_Plus_2": "202331_at", "HG-U95Av2": "37704_at", "HTA-2_0": "TC19002636.hg.1", "HuEx-1_0": "3834205", "HuGene-1_1": "8029065", "HuGene-2_1": "16862504"}, "retired": 5014, "summary": "The branched-chain alpha-keto acid (BCAA) dehydrogenase (BCKD) complex is an innter mitochondrial enzyme complex that catalyzes the second major step in the catabolism of the branched-chain amino acids leucine, isoleucine, and valine. The BCKD complex consists of three catalytic components: a heterotetrameric (alpha2-beta2) branched-chain alpha-keto acid decarboxylase (E1), a dihydrolipoyl transacylase (E2), and a dihydrolipoamide dehydrogenase (E3). This gene encodes the alpha subunit of the decarboxylase (E1) component. Mutations in this gene result in maple syrup urine disease, type IA. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009].", "symbol": "BCKDHA", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412759"}, "unigene": "Hs.433307", "uniprot": {"Swiss-Prot": "P12694", "TrEMBL": ["H0YH31", "Q59EI3", "H0YH20", "F5GXU9"]}, "wikipedia": {"url_stub": "BCKDHA"}}